BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32623502)

  • 1. Comprehensive evaluation of
    Gao J; Xu Q; Fu Y; He K; Zhang C; Zhang Q; Shi J; Zhao X; Wang F; Guo H
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):561-569. PubMed ID: 32623502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-head comparisons of enhanced CT, 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in identifying adverse pathology of clear-cell renal cell carcinoma: a prospective study.
    Chen SH; Lin BH; Chen SM; Qiu QR; Ruan ZT; Chen ZJ; Wei Y; Zheng QS; Xue XY; Miao WB; Xu N
    Int Braz J Urol; 2023; 49(6):716-731. PubMed ID: 37624658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Lin R; Wang C; Chen S; Lin T; Cai H; Chen S; Yang Y; Zhang J; Xu F; Zhang J; Chen X; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):535-547. PubMed ID: 37728667
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Gao J; Meng L; Xu Q; Zhao X; Deng Y; Fu Y; Guo S; He K; Shi J; Wang F; Zhang S; Guo H
    Mol Imaging Biol; 2022 Oct; 24(5):759-768. PubMed ID: 35451707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Meng L; Zhang S; Gao J; Xu Q; Fu Y; Zhou YH; Wang F; Guo H
    Eur Radiol; 2022 Sep; 32(9):6545-6553. PubMed ID: 35357538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-[
    Zhao Y; Wu C; Li W; Chen X; Li Z; Liao X; Cui Y; Zhao G; Liu M; Fu Z
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):570-579. PubMed ID: 32814979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of [
    Wang G; Li L; Wang J; Zang J; Chen J; Xiao Y; Fan X; Zhu L; Kung HF; Zhu Z
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1499-1509. PubMed ID: 36600099
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
    J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's behind
    Rüschoff JH; Ferraro DA; Muehlematter UJ; Laudicella R; Hermanns T; Rodewald AK; Moch H; Eberli D; Burger IA; Rupp NJ
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4042-4053. PubMed ID: 34386839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of negative
    Celli M; De Giorgi U; Caroli P; Di Iorio V; Fantini L; Rossetti V; Foca F; Nicolini S; Giganti M; Paganelli G; Matteucci F
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):87-94. PubMed ID: 32588090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and prospective validation of an SUV
    Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
    Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
    [No Abstract]   [Full Text] [Related]  

  • 15. Can
    Yin H; Chen M; Qiu X; Qiu L; Gao J; Li D; Fu Y; Huang H; Guo S; Zhang Q; Ai S; Wang F; Guo H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3693-3701. PubMed ID: 33813594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
    Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
    J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of
    Wang B; Deng Y; Xu Q; Gao J; Shen H; He X; Ding Q; Wang F; Guo H
    Clin Radiol; 2023 May; 78(5):e417-e424. PubMed ID: 36805287
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zhang L; Zhao H; Jiang H; Zhao H; Han W; Wang M; Fu P
    Abdom Radiol (NY); 2021 Dec; 46(12):5618-5628. PubMed ID: 34455450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[
    Wu C; Cui Y; Liu J; Ma L; Xiong Y; Gong Y; Zhao Y; Zhang X; Chen S; He Q; Zhang J; Liu M; Fan Y
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4054-4066. PubMed ID: 33978830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.